DIRECTOR :
SWAPNIL JATINBHAI SHAH
As On :
Tuesday, 26 November 2024
Total Page Views : 5 | Name | SWAPNIL JATINBHAI SHAH |
| Total Companies | 11 |
| First Appointment Date | Monday, 21 September 2015 |
| Last Resigned Date | |
| Social Links | |
SWAPNIL JATINBHAI SHAH was appointed on Monday, 21 September 2015 with REMUS PHARMACEUTICALS PRIVATE LIMITED - AHMEDABAD - Total Tenure of 9 Year(s), 2 month(s), 5 day(s), and also appointed on Monday, 21 September 2015 with REMUS PHARMACEUTICALS LIMITED - AHMEDABAD - Total Tenure of 9 Year(s), 2 month(s), 5 day(s), and also appointed on Monday, 21 November 2016 with RELIUS LIFESCIENCES PRIVATE LIMITED - AHMEDABAD - Total Tenure of 8 Year(s), 0 month(s), 5 day(s), and also appointed on Friday, 25 November 2016 with ESPEE THERAPEUTICS LLP - AHMEDABAD - Total Tenure of 8 Year(s), 0 month(s), 1 day(s), and also appointed on Tuesday, 26 December 2017 with SENORES PHARMACEUTICALS PRIVATE LIMITED - AHMEDABAD - Total Tenure of 6 Year(s), 11 month(s), 0 day(s), and also appointed on Monday, 13 August 2018 with SUMER ENTERPRISES LLP - AHMEDABAD - Total Tenure of 6 Year(s), 3 month(s), 13 day(s), and also appointed on Friday, 03 May 2019 with AELIUS PROJECTS LLP - AHMEDABAD - Total Tenure of 5 Year(s), 6 month(s), 23 day(s), and also appointed on Wednesday, 22 May 2019 with RENOSEN PHARMACEUTICALS PRIVATE LIMITED - AHMEDABAD - Total Tenure of 5 Year(s), 6 month(s), 4 day(s), and also appointed on Friday, 15 January 2021 with RATNAMANI HEALTHCARE PRIVATE LIMITED - AHMEDABAD - Total Tenure of 3 Year(s), 10 month(s), 11 day(s), and also appointed on Wednesday, 15 September 2021 with RATNAGENE LIFESCIENCE PRIVATE LIMITED - AHMEDABAD - Total Tenure of 3 Year(s), 2 month(s), 11 day(s), and also appointed on Friday, 15 October 2021 with SENORES PHARMACEUTICALS LIMITED - AHMEDABAD - Total Tenure of 3 Year(s), 1 month(s), 11 day(s)
| Rank | Logo | CIN | Company Name | City | Appointed Date | Resign Date | Date of Incorporation | Status |
|---|
| 1243970 |  | U24232GJ2015PTC084536 | REMUS PHARMACEUTICALS PRIVATE LIMITED | AHMEDABAD | Monday, 21 September 2015 | | Monday, 21 September 2015 | |
| 107044 |  | U24232GJ2015PLC084536 | REMUS PHARMACEUTICALS LIMITED | AHMEDABAD | Monday, 21 September 2015 | | Monday, 21 September 2015 | |
| 1857943 |  | U24299GJ2016PTC094454 | RELIUS LIFESCIENCES PRIVATE LIMITED | AHMEDABAD | Monday, 21 November 2016 | | Monday, 21 November 2016 | |
| 2578534 |  | AAH-8938 | ESPEE THERAPEUTICS LLP | AHMEDABAD | Friday, 25 November 2016 | | Friday, 25 November 2016 | |
| 59037 | | U24290GJ2017PTC100263 | SENORES PHARMACEUTICALS PRIVATE LIMITED | AHMEDABAD | Tuesday, 26 December 2017 | | Tuesday, 26 December 2017 | |
| 2854429 | | AAN-1429 | SUMER ENTERPRISES LLP | AHMEDABAD | Monday, 13 August 2018 | | Monday, 13 August 2018 | |
| 2926815 | | AAP-1775 | AELIUS PROJECTS LLP | AHMEDABAD | Friday, 03 May 2019 | | Friday, 03 May 2019 | |
| 2181967 | | U51909GJ2019PTC108258 | RENOSEN PHARMACEUTICALS PRIVATE LIMITED | AHMEDABAD | Wednesday, 22 May 2019 | | Wednesday, 22 May 2019 | |
| 61505 |  | U24230GJ2005PTC047394 | RATNAMANI HEALTHCARE PRIVATE LIMITED | AHMEDABAD | Friday, 15 January 2021 | | Thursday, 29 December 2005 | |
| 167534 | | U24231GJ2021PTC125613 | RATNAGENE LIFESCIENCE PRIVATE LIMITED | AHMEDABAD | Wednesday, 15 September 2021 | | Wednesday, 15 September 2021 | |
| 11102 | | U24290GJ2017PLC100263 | SENORES PHARMACEUTICALS LIMITED | AHMEDABAD | Friday, 15 October 2021 | | Tuesday, 26 December 2017 | |
Suit Filed accounts of Rs. 25 Lacs and above Total Suit Filed : 0
| # | Category | Bank / FI | Branch | Outstanding Amount
In Lacs | Asset Classification | Date Of Classification | Suit |
|---|
Report Director Information Discrepancy
The information shown on this page was last updated onTuesday, 26 November 2024
Due to frequent changes in Director Information, it is possible that some details you see may be out-of-date. If you feel the information is not up-to-date, you may request to get this page auto-updated now.
Request For Update If you still notice any discrepancy, please help by reporting it to us.
We appreciate your help!
Report Discrepancy 
